Julia Karow

NHGRI researchers showed that they were able to extract more useful pharmacogenetic information from exome data than from current chip data. 

Last year, Radboud University Medical Centre's genetics lab conducted about 6,000 diagnostic exome tests and ran 2,000 nex-gen sequencing-based BRCA1/2 hereditary cancer assays.

Last week, the G-BA, a committee that decides about reimbursable medical services in Germany, said it will start a methods evaluation of noninvasive prenatal testing.

The project has recruited nearly half of the 1,000 families it plans to analyze and has completed the exome analysis for about 160.